Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

Clinical trial NCT02158702 · UNKNOWN

Trial details

NCT number: NCT02158702
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Relapse After Use of Lenalidomide and Bortezomib

Start date: 2014-11-01
Primary completion: 2018-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.